Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
about
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patientsAntifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsAntifungal Therapy in Hematopoietic Stem Cell Transplant RecipientsAmphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents.Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropeniaSystematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Canadian clinical practice guidelines for invasive candidiasis in adults.A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines. Infectious Diseases Society of America.Treatment of documented and suspected neutropenia-associated invasive fungal infections.Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysisClinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazoleUpdated guidelines for managing fungal diseases in hematology patients.Empiric antifungal therapy in patients with febrile neutropenia.Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.Conventional and alternative antifungal therapies to oral candidiasis.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy.Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin.Antifungal therapy in 'bone marrow failure'.Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32:320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32:321).Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis.[Candidiasis in cancer patients: Epidemiology, diagnosis, prophylaxis and therapy]Identification of medically important fungi by the Pyrosequencing technology.Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive Mycoses
P2860
Q24193785-DE499F7B-29F9-4BDC-B169-408E831076E1Q24239978-1D4F6ED1-91B3-4C77-AB18-5C28A0FE365BQ28080147-2DAF064C-625F-4B01-AA71-B4B764D26BB2Q30887333-0F581DF6-7A93-48EB-96BC-5A049A1DF512Q33253851-0990D3C5-7D36-4A41-9641-C599CA81666EQ33265510-F49E3713-AFB1-4102-BAB7-7DB66DAC0C90Q33876645-1B088396-99EE-4692-BD7D-7F1E5E39F630Q34114674-3C2EAF09-3FD9-40ED-8135-1698C5877125Q34237335-07FB2042-EDF7-4254-95E1-4D041C0D9AF2Q34335250-680D7918-E1D8-4F70-9E01-6D0EC596B67BQ34590013-F1004F5E-4BB4-492E-AECF-CEF59C565E85Q36285521-B7F50584-7E63-40CB-82C4-E83843694CAAQ36769211-DEAC26AD-F785-49DC-8DF9-1643C0655294Q37785548-12991709-D11D-47C3-8C66-0ACF1660F0D8Q37859365-D9224F5F-5CB7-42B6-81AB-0E89F4749E98Q37873552-4FE77A83-F897-4B76-BABD-94195A0EB857Q38137060-E748D07D-1F0D-4E55-93A2-06D192161B46Q38284468-1959411F-F74B-431E-874D-75C0EFFEC56BQ40446187-5201AD98-0F40-43E5-A1BE-3876A3557B75Q40454115-D1B8E103-BDBE-47F4-BF9F-2A8A7E9DCB22Q40487519-AE1DC1A6-7D42-44EE-98A4-DB86622EDA50Q40489288-E08C7C6E-9268-4576-9002-83FB60A2A21BQ41733799-DC772CAF-D6E8-4602-9895-33214C498BF7Q43523936-20A0A776-E5CF-48CC-91AC-4927CD9E032DQ43696321-2AE1246A-E3C9-4D15-81CD-8ABD91ADD355Q44091566-4B4C2936-4DBD-4A24-A3F0-1B65F9D8D704Q48202469-BC31D148-D262-49D3-9CC8-906CB53B82DFQ56837353-61B2B5C7-DFBB-4B8E-9920-E784A496A9C6
P2860
Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Fluconazole versus amphoterici ...... and randomised clinical trial.
@en
type
label
Fluconazole versus amphoterici ...... and randomised clinical trial.
@en
prefLabel
Fluconazole versus amphoterici ...... and randomised clinical trial.
@en
P2093
P1476
Fluconazole versus amphoterici ...... and randomised clinical trial
@en
P2093
E Castagnola
F Menichetti
M Giacchino
M T Van Lint
P304
P356
10.1016/0959-8049(95)00619-2
P577
1996-05-01T00:00:00Z